Back to Trades
Alenson Carman
See RemarksCIK 0001688865
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Alenson Carman, See Remarks, accounts for 2 disclosed filings worth $3.4M, all concentrated in Prime Medicine, Inc. (PRME), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Feb 24 | PRME Prime Medicine, Inc. | Alenson Carman | See Remarks | Award | $467.6K |
| Aug 5 | PRME Prime Medicine, Inc. | Alenson Carman | See Remarks | Award | $3.0M |
2 filings